List of insiders holdings for ACADIA PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | BAKER BROS. ADVISORS LP 14159 L.P. 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
2023-05-24 17:11:36 | 43,227,599 0 |
43,227,599 | Form 13D |
| 2 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
2024-05-31 16:10:16 | 205,752 39,413,587 |
39,619,339 | Form 4 |
| 3 | GORDON CARL L Director |
2005-04-22 17:16:41 | 0 1,485,512 |
1,485,512 | Form 4 |
| 4 | NOMURA INTERNATIONAL PLC Nomura Phase4 Ventures LTD Nomura Phase4 Ventures GP LTD Nomura Phase4 Ventures LP Member of 13G Group (1) 10% Owner |
2010-02-12 14:28:15 | 549,752 0 |
549,752 | Form 13G |
| 5 | Hacksell Uli CEO |
2015-02-19 17:58:47 | 313,500 115,549 |
429,049 | Form 4 |
| 6 | Owen Adams Catherine Chief Executive Officer |
2025-03-26 19:49:52 | 414,015 0 |
414,015 | Form 4 |
| 7 | Brann Mark R President & CSO |
2006-06-19 16:23:17 | 52,593 317,756 |
370,349 | Form 4 |
| 8 | Williamson Douglas J Executive VP, Research & Dev |
2023-02-13 18:45:02 | 287,951 0 |
287,951 | Form 4 |
| 9 | Garner Thomas EVP, Chief Commercial Officer |
2024-12-10 18:33:31 | 281,221 0 |
281,221 | Form 4 |
| 10 | DAVIS STEPHEN CEO |
2024-08-20 18:40:42 | 186,555 0 |
186,555 | Form 4 |
| 11 | Mills Roger EVP, DEVELOPMENT AND CMO |
2015-03-24 18:00:25 | 180,000 0 |
180,000 | Form 4 |
| 12 | GRAY MARY ANN Director |
2016-06-09 17:28:57 | 149,476 0 |
149,476 | Form 4 |
| 13 | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC |
2025-03-26 20:03:28 | 133,371 0 |
133,371 | Form 4 |
| 14 | Richards Douglas E VP of Business Development |
2004-05-26 21:34:49 | 120,000 0 |
120,000 | Form 3 |
| 15 | Thompson Elizabeth H.Z. EVP, Head of Research & Dev |
2025-03-26 19:52:56 | 118,256 0 |
118,256 | Form 4 |
| 16 | Aasen Thomas H EXEC VP, CFO AND CBO |
2014-04-04 19:51:23 | 106,819 0 |
106,819 | Form 4 |
| 17 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL |
2024-11-19 20:43:42 | 81,931 0 |
81,931 | Form 4 |
| 18 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
2025-04-08 19:40:13 | 64,732 0 |
64,732 | Form 4 |
| 19 | Stankovic Srdjan R. President |
2022-11-22 16:34:37 | 61,234 0 |
61,234 | Form 4 |
| 20 | SOLAND DANIEL B Director |
2024-05-31 18:00:10 | 60,000 0 |
60,000 | Form 4 |
| 21 | HARRIGAN EDMUND Director |
2024-05-31 18:00:13 | 51,000 0 |
51,000 | Form 4 |
| 22 | Daly James M Director |
2024-05-31 18:00:16 | 50,000 0 |
50,000 | Form 4 |
| 23 | KIM AUSTIN D. EVP,General Counsel, Secretary |
2024-01-09 18:00:29 | 46,901 0 |
46,901 | Form 4 |
| 24 | Brege Laura Director |
2024-05-31 18:00:07 | 45,500 0 |
45,500 | Form 4 |
| 25 | WALTON ALAN G Director |
2009-06-16 16:22:08 | 44,722 0 |
44,722 | Form 4 |
| 26 | Kaiser John Joseph VP, Strat. Mrkting & Com. Dev. |
2008-10-22 19:38:07 | 40,000 0 |
40,000 | Form 4 |
| 27 | Iversen Leslie L Director |
2016-04-20 17:37:28 | 36,127 0 |
36,127 | Form 4 |
| 28 | Tolf Bo-Ragnar VP/Mg. Dir. ACADIA Pharma AB |
2009-07-09 16:39:38 | 35,000 0 |
35,000 | Form 4 |
| 29 | Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER |
2017-03-10 20:37:19 | 33,750 0 |
33,750 | Form 4 |
| 30 | Davis Robert E Exec. VP, Drug Discovery |
2005-03-15 20:52:26 | 30,000 0 |
30,000 | Form 4 |
| 31 | Baity Glenn EVP AND GC |
2018-04-20 18:37:24 | 28,125 0 |
28,125 | Form 4 |
| 32 | Kihara James PRINCIPAL ACCOUNTING OFFICER |
2025-04-08 19:38:59 | 24,267 0 |
24,267 | Form 4 |
| 33 | YOUNG TODD S. EVP AND CFO |
2018-10-24 16:27:12 | 23,438 0 |
23,438 | Form 4 |
| 34 | GAROFALO ELIZABETH A. Director |
2025-03-06 18:30:15 | 17,595 0 |
17,595 | Form 4 |
| 35 | Ridloff Elena EVP and CFO |
2021-04-30 18:55:12 | 17,044 0 |
17,044 | Form 4 |
| 36 | KAPLAN LESTER J PH D Director |
2015-08-13 17:10:12 | 17,000 0 |
17,000 | Form 4 |
| 37 | YANG MICHAEL J. EVP and CCO |
2021-01-08 19:31:12 | 16,226 0 |
16,226 | Form 4 |
| 38 | Lundstrom Brian Sr. VP, Bus. Development |
2008-03-11 20:06:11 | 16,000 0 |
16,000 | Form 4 |
| 39 | Ndu Adora Director |
2024-10-15 18:05:05 | 15,414 0 |
15,414 | Form 4 |
| 40 | BORER MICHAEL T Director |
2015-06-17 19:06:59 | 12,500 0 |
12,500 | Form 4 |
| 41 | Rasmussen Torsten Director |
2015-06-17 19:10:36 | 0 12,500 |
12,500 | Form 4 |
| 42 | Wells William McDowall Director |
2015-06-17 19:11:56 | 12,500 0 |
12,500 | Form 4 |
| 43 | van Osch Martien Director |
2005-06-14 16:37:12 | 11,584 0 |
11,584 | Form 4 |
| 44 | Binder Gordon M Director |
2009-06-16 16:05:13 | 10,000 0 |
10,000 | Form 4 |
| 45 | Miller Eric Alejandro Controller & PAO |
2019-10-17 18:26:38 | 1,524 0 |
1,524 | Form 4 |
| 46 | Biggar Stephen R Director |
2013-01-23 16:41:51 | 0 0 |
0 | Form 3 |
| 47 | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G 10% Owner |
2011-02-14 10:32:00 | 0 0 |
0 | Form 13G |